Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication

Editorial

  • 227 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 22
  • 23
  • Next →
After further review
Laurence A. Turka
Laurence A. Turka
Published May 1, 2009
Citation Information: J Clin Invest. 2009;119(5):1057-1057. https://doi.org/10.1172/JCI39392.
View: Text | PDF

After further review

  • Text
  • PDF
Abstract

In the two years that I have been Editor in Chief of the JCI, the editors and I have sent approximately 2,500 papers for external review. The referee reports that we’ve received have spanned the spectrum from incredibly insightful to completely unhelpful. Together with a longer piece immediately following this editorial, I would like to reflect on what I think makes a good review.

Authors

Laurence A. Turka

×

All data are not created equal
Ushma S. Neill
Ushma S. Neill
Published March 2, 2009
Citation Information: J Clin Invest. 2009;119(3):424-424. https://doi.org/10.1172/JCI38802.
View: Text | PDF

All data are not created equal

  • Text
  • PDF
Abstract

An inauspicious start to 2009, unfortunately. This issue may seem a little thinner than others we’ve recently published, as 4 articles that were previously accepted and scheduled for publication in this issue will not appear. We continue to screen all figures from accepted manuscripts, and we continue to find irregularities. In several cases, the alterations in the figures led to the discovery of some fundamental problems with the data. Many of the papers suffered from the same problems, and this led us to consider whether it was time to revisit some experimental basics.

Authors

Ushma S. Neill

×

Bothered and bewildered, but not bewitched
Ushma S. Neill, Laurence A. Turka
Ushma S. Neill, Laurence A. Turka
Published November 3, 2008
Citation Information: J Clin Invest. 2008;118(11):3516-3516. https://doi.org/10.1172/JCI37695.
View: Text | PDF

Bothered and bewildered, but not bewitched

  • Text
  • PDF
Abstract

Unfortunately, we seem to run article amendments (corrections, errata, retractions, addenda) in every issue these days. In the current issue, we have a correction and a retraction — both coming after intensive investigations and peculiar situations we hadn’t encountered before.

Authors

Ushma S. Neill, Laurence A. Turka

×

Senator, what is your policy on . . . “Other”?
Laurence A. Turka
Laurence A. Turka
Published September 2, 2008
Citation Information: J Clin Invest. 2008;118(9):2988-2988. https://doi.org/10.1172/JCI37035.
View: Text | PDF

Senator, what is your policy on . . . “Other”?

  • Text
  • PDF
Abstract

In the midst of the monumentally important 2008 presidential election, information about the candidates’ proposals for biomedical research is notably absent. Why is this the case, and more importantly, what can be done about it?

Authors

Laurence A. Turka

×

Publish or perish, but at what cost?
Ushma S. Neill
Ushma S. Neill
Published July 1, 2008
Citation Information: J Clin Invest. 2008;118(7):2368-2368. https://doi.org/10.1172/JCI36371.
View: Text | PDF

Publish or perish, but at what cost?

  • Text
  • PDF
Abstract

The academic scientific enterprise rewards those with the longest CVs and the most publications. Under pressure to generate voluminous output, scientists often fall prey to double publishing, self plagiarism, and submitting the “minimal publishable unit.” Are these ethical gray areas, or true transgressions?

Authors

Ushma S. Neill

×

Animal house
Laurence A. Turka
Laurence A. Turka
Published March 3, 2008
Citation Information: J Clin Invest. 2008;118(3):822-822. https://doi.org/10.1172/JCI35214.
View: Text | PDF

Animal house

  • Text
  • PDF
Abstract

While the JCI was originally conceived as a journal that would integrate various scientific approaches to the examination of human physiology and pathophysiology, we now find many of its pages filled with animal models of human disease. Is this a good thing?

Authors

Laurence A. Turka

×

A method to our madness
Laurence A. Turka
Laurence A. Turka
Published November 1, 2007
Citation Information: J Clin Invest. 2007;117(11):3144-3144. https://doi.org/10.1172/JCI34071.
View: Text | PDF

A method to our madness

  • Text
  • PDF
Abstract

Until recently, journal editorial operations and decisions seemed impenetrable to me. Now I have a view from the inside out.

Authors

Laurence A. Turka

×

Navigating through the gray (and CMYK) areas of figure manipulation: rules at the JCI
Ushma Neill, Laurence A. Turka
Ushma Neill, Laurence A. Turka
Published October 1, 2007
Citation Information: J Clin Invest. 2007;117(10):2736-2736. https://doi.org/10.1172/JCI33829.
View: Text | PDF

Navigating through the gray (and CMYK) areas of figure manipulation: rules at the JCI

  • Text
  • PDF
Abstract

Since it seems many of the articles we’re accepting continue to have image rearrangements and changes in them that are not consistent with JCI policy, we thought it might be a good idea to spell out exactly what is, and more importantly what isn’t, allowed.

Authors

Ushma Neill, Laurence A. Turka

×

Lost in a dark wood
Laurence A Turka
Laurence A Turka
Published July 2, 2007
Citation Information: J Clin Invest. 2007;117(7):1734-1735. https://doi.org/10.1172/JCI32797.
View: Text | PDF

Lost in a dark wood

  • Text
  • PDF
Abstract

Authors

Laurence A Turka

×

Evolution, not revolution
Laurence A. Turka
Laurence A. Turka
Published March 1, 2007
Citation Information: J Clin Invest. 2007;117(3):504-505. https://doi.org/10.1172/JCI31465.
View: Text | PDF

Evolution, not revolution

  • Text
  • PDF
Abstract

A new sheriff is in town: as of March 1, 2007, the editorial board of the JCI will be based at the University of Pennsylvania. While our core mission to provide the best venue for biomedical research remains the same, we plan a number of refinements that we hope will benefit our readers, authors, and referees.

Authors

Laurence A. Turka

×
  • ← Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 22
  • 23
  • Next →

No posts were found with this tag.

Advertisement
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts